Professor of Pharmacology at the Hebrew University Medical Center in Jerusalem, where she also headed the department from 1983 to 1986.
She has received several awards, also from the Ageing Institute, USA, for the invention of the Exelon, a treatment for Alzheimer’s Disease. In the past 16 years she has been responsible for pre-clinical research on a new anti-Alzheimer drug, ladostigil.
Prof. Rosin has shown that it confers neuroprotective activity and anti-depressive as well as improvements in cognition. She was elected President of the Israel Society of Neuroscience from 2003 to 2005. During her career she has been a member of the editorial board of several journals of pharmacology and neuroscience, many university committees and the Committee of the Israel Society of Psychobiology. Besides pharmaceutical development, her research focuses on neuro chemical and hormonal mechanisms that underline the alterations in behavior induced by prenatal stress.